Literature DB >> 24869935

Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis.

Albert W Cheng1, Jiahai Shi2, Piu Wong2, Katherine L Luo3, Paula Trepman3, Eric T Wang4, Heejo Choi3, Christopher B Burge3, Harvey F Lodish5.   

Abstract

The scope and roles of regulated isoform gene expression during erythroid terminal development are poorly understood. We identified hundreds of differentiation-associated isoform changes during terminal erythropoiesis. Sequences surrounding cassette exons of skipped exon events are enriched for motifs bound by the Muscleblind-like (MBNL) family of splicing factors. Knockdown of Mbnl1 in cultured murine fetal liver erythroid progenitors resulted in a strong block in erythroid differentiation and disrupted the developmentally regulated exon skipping of Ndel1 mRNA, which is bound by MBNL1 and critical for erythroid terminal proliferation. These findings reveal an unanticipated scope of the alternative splicing program and the importance of Mbnl1 during erythroid terminal differentiation.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24869935      PMCID: PMC4110662          DOI: 10.1182/blood-2013-12-542209

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Loss of E2F4 activity leads to abnormal development of multiple cellular lineages.

Authors:  R E Rempel; M T Saenz-Robles; R Storms; S Morham; S Ishida; A Engel; L Jakoi; M F Melhem; J M Pipas; C Smith; J R Nevins
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

Review 2.  Alternative pre-mRNA splicing and proteome expansion in metazoans.

Authors:  Tom Maniatis; Bosiljka Tasic
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

Review 3.  From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications.

Authors:  Shilpa M Hattangadi; Piu Wong; Lingbo Zhang; Johan Flygare; Harvey F Lodish
Journal:  Blood       Date:  2011-10-12       Impact factor: 22.113

4.  SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts.

Authors:  V Visconte; H Makishima; A Jankowska; H Szpurka; F Traina; A Jerez; C O'Keefe; H J Rogers; M A Sekeres; J P Maciejewski; R V Tiu
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

5.  Spliceosome mutations in hematopoietic malignancies.

Authors:  Christopher N Hahn; Hamish S Scott
Journal:  Nat Genet       Date:  2011-12-27       Impact factor: 38.330

6.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

7.  E2F4 is essential for normal erythrocyte maturation and neonatal viability.

Authors:  P O Humbert; C Rogers; S Ganiatsas; R L Landsberg; J M Trimarchi; S Dandapani; C Brugnara; S Erdman; M Schrenzel; R T Bronson; J A Lees
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

8.  Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Authors:  Luca Malcovati; Elli Papaemmanuil; David T Bowen; Jacqueline Boultwood; Matteo G Della Porta; Cristiana Pascutto; Erica Travaglino; Michael J Groves; Anna L Godfrey; Ilaria Ambaglio; Anna Gallì; Matteo C Da Vià; Simona Conte; Sudhir Tauro; Norene Keenan; Ann Hyslop; Jonathan Hinton; Laura J Mudie; James S Wainscoat; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Eva Hellström-Lindberg; Mario Cazzola
Journal:  Blood       Date:  2011-10-12       Impact factor: 22.113

9.  Human Nudel and NudE as regulators of cytoplasmic dynein in poleward protein transport along the mitotic spindle.

Authors:  Xiumin Yan; Fang Li; Yun Liang; Yidong Shen; Xiangshan Zhao; Qiongping Huang; Xueliang Zhu
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

10.  Mammalian erythroblast enucleation requires PI3K-dependent cell polarization.

Authors:  Junxia Wang; Tzutzuy Ramirez; Peng Ji; Senthil Raja Jayapal; Harvey F Lodish; Maki Murata-Hori
Journal:  J Cell Sci       Date:  2012-02-13       Impact factor: 5.285

View more
  27 in total

1.  KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome.

Authors:  Graham W Magor; Michael R Tallack; Kevin R Gillinder; Charles C Bell; Naomi McCallum; Bronwyn Williams; Andrew C Perkins
Journal:  Blood       Date:  2015-02-27       Impact factor: 22.113

2.  Erythroid mRNA processing: a "splice of life".

Authors:  Don M Wojchowski
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

Review 3.  Alternative splicing as a regulator of development and tissue identity.

Authors:  Francisco E Baralle; Jimena Giudice
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

4.  A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages.

Authors:  Christopher R Edwards; William Ritchie; Justin J-L Wong; Ulf Schmitz; Robert Middleton; Xiuli An; Narla Mohandas; John E J Rasko; Gerd A Blobel
Journal:  Blood       Date:  2016-03-09       Impact factor: 22.113

Review 5.  RNA splicing during terminal erythropoiesis.

Authors:  John G Conboy
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

6.  The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness.

Authors:  Dillon M Voss; Anthony Sloan; Raffaella Spina; Heather M Ames; Eli E Bar
Journal:  Cancer Res       Date:  2020-09-14       Impact factor: 12.701

7.  Alternative splicing of EKLF/KLF1 in murine primary erythroid tissues.

Authors:  Yvette Y Yien; Merlin Nithya Gnanapragasam; Ritama Gupta; Stefano Rivella; James J Bieker
Journal:  Exp Hematol       Date:  2014-10-02       Impact factor: 3.084

Review 8.  Regulators of cardiac fibroblast cell state.

Authors:  Ross Bretherton; Darrian Bugg; Emily Olszewski; Jennifer Davis
Journal:  Matrix Biol       Date:  2020-05-19       Impact factor: 11.583

9.  FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity.

Authors:  Yvette Y Yien; Jiahai Shi; Caiyong Chen; Jesmine T M Cheung; Anthony S Grillo; Rishna Shrestha; Liangtao Li; Xuedi Zhang; Martin D Kafina; Paul D Kingsley; Matthew J King; Julien Ablain; Hojun Li; Leonard I Zon; James Palis; Martin D Burke; Daniel E Bauer; Stuart H Orkin; Carla M Koehler; John D Phillips; Jerry Kaplan; Diane M Ward; Harvey F Lodish; Barry H Paw
Journal:  J Biol Chem       Date:  2018-10-26       Impact factor: 5.157

10.  Inhibition of lncRNA MAAT Controls Multiple Types of Muscle Atrophy by cis- and trans-Regulatory Actions.

Authors:  Jin Li; Tingting Yang; Haifei Tang; Zhao Sha; Rui Chen; Lei Chen; Yan Yu; Glenn C Rowe; Saumya Das; Junjie Xiao
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.